Trial Profile
A Phase I/II, Randomized, Controlled, Double Blind, Study of Chondrogen - Adult Universal Cell Delivered by Intra-Articular Injection Following Meniscectomy in Patients 18-60 Years
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Oct 2020
Price :
$35
*
At a glance
- Drugs Mesenchymal stem cell therapy (Primary) ; Hyaluronic acid
- Indications Knee injuries; Meniscus disorders
- Focus Therapeutic Use
- Sponsors Osiris Therapeutics
- 22 May 2014 New trial record